Overview

Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of EN3267 in treating breakthrough pain episodes in opioid cancer patients who are using stable doses of opioid medication.
Phase:
Phase 3
Details
Lead Sponsor:
Prostrakan Pharmaceuticals
Treatments:
Fentanyl